PF-04691502, a Potent and Selective Oral Inhibitor of PI3K and mTOR Kinases with Antitumor Activity
Jing Yuan(Scripps Research Institute), Shubha Bagrodia(Scripps Research Institute)
Cited by 160
Related Papers
Changing Brain Metabolism Patterns in Patients With ANMDARE
|Clinical Nuclear Medicine|2016|61